Abstract
In certain physiological or pathological states (e.g., starvation, heat shock, or muscle atrophy) and upon drug treatments, the overall rate of protein degradation in cells may increase or decrease. These adaptations and pathological responses can occur through alterations in substrate flux through the ubiquitin-proteasome pathway (UPP), the autophagy-lysosomal system, or both. Therefore, it is important to precisely measure the activities of these degradation pathways in degrading cell proteins under different physiological states or upon treatment with drugs. In particular, proteasome inhibitors have become very important agents for treating multiple myeloma and very useful tools in basic research. To evaluate rigorously their efficacy and the cellular responses to other inhibitors, it is essential to know the degree of inhibition of protein breakdown. Unfortunately, commonly used assays of the activities of the UPP or autophagy rely on qualitative, indirect approaches that do not directly reflect the actual rates of protein degradation by these pathways. In this chapter, we describe isotopic pulse-chase methods to directly measure overall rates of protein degradation in cells by radiolabeling cell proteins and following their subsequent degradation to radioactive amino acids, which diffuse from cells into the medium and can be easily quantitated. While pulse-chase methods have often been used to follow degradation of specific proteins, the methods described here allow quantification of the total cellular activity in degrading either long-lived proteins (the great bulk of cell constituents) or the fraction with short half-lives. Moreover, by use of specific inhibitors of proteasomes or lysosomes, it is also possible to measure precisely the total contributions of the UPP or lysosomal proteases. These approaches have already been proven very useful in defining the effects of inhibitors, growth factors, nutrients, ubiquitination, and different proteasome activators on overall proteolysis and on substrate flux through the proteasomal and lysosomal pathways.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Voges D, Zwickl P, Baumeister W (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015–1068
Klionsky DJ, Ohsumi Y (1999) Vacuolar import of proteins and organelles from the cytoplasm. Annu Rev Cell Dev Biol 15:1–32. https://doi.org/10.1146/annurev.cellbio.15.1.1
Myeku N, Clelland CL, Emrani S, Kukushkin NV, Yu WH et al (2016) Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat Med 22(1):46–53. https://doi.org/10.1038/nm.4011
Zhao J, Brault JJ, Schild A, Cao P, Sandri M et al (2007) FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6(6):472–483. https://doi.org/10.1016/j.cmet.2007.11.004
Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E et al (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117(3):399–412
Demo SD, Kirk CJ, Aujay MA, Buchholz TJ, Dajee M et al (2007) Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome. Cancer Res 67(13):6383–6391
Cusack JC Jr, Liu R, Xia L, Chao TH, Pien C et al (2006) NPI-0052 enhances tumoricidal response to conventional cancer therapy in a colon cancer model. Clin Cancer Res 12(22):6758–6764
Petroski MD (2008) The ubiquitin system, disease, and drug discovery. BMC Biochem 9(Suppl 1):S7
Kisselev AF, Goldberg AL (2001) Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8(8):739–758
Gu C, Kolodziejek I, Misas-Villamil J, Shindo T, Colby T et al (2010) Proteasome activity profiling: a simple, robust and versatile method revealing subunit-selective inhibitors and cytoplasmic, defense-induced proteasome activities. Plant J 62(1):160–170. https://doi.org/10.1111/j.1365-313X.2009.04122.x
de Bruin G, Xin BT, Florea BI, Overkleeft HS (2016) Proteasome subunit selective activity-based probes report on proteasome core particle composition in a native polyacrylamide gel electrophoresis fluorescence-resonance energy transfer assay. J Am Chem Soc 138(31):9874–9880. https://doi.org/10.1021/jacs.6b04207
Tanaka K (1994) Role of proteasomes modified by interferon-gamma in antigen processing. J Leukoc Biol 56(5):571–575
Peth A, Besche HC, Goldberg AL (2009) Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening. Mol Cell 36(5):794–804. https://doi.org/10.1016/j.molcel.2009.11.015
Collins GA, Goldberg AL (2017) The logic of the 26S proteasome. Cell 169(5):792–806. https://doi.org/10.1016/j.cell.2017.04.023
Zhao J, Goldberg AL (2016) Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR. Autophagy 12(10):1967–1970. https://doi.org/10.1080/15548627.2016.1205770
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H et al (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12(1):1–222. https://doi.org/10.1080/15548627.2015.1100356
Guo X, Wang X, Wang Z, Banerjee S, Yang J et al (2016) Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis. Nat Cell Biol 18(2):202–212. https://doi.org/10.1038/ncb3289
Lokireddy S, Kukushkin NV, Goldberg AL (2015) cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins. Proc Natl Acad Sci U S A 112(52):E7176–E7185. https://doi.org/10.1073/pnas.1522332112
Kisselev AF, Callard A, Goldberg AL (2006) Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J Biol Chem 281(13):8582–8590. https://doi.org/10.1074/jbc.M509043200
Goldberg AL (1972) Degradation of abnormal proteins in Escherichia coli (protein breakdown-protein structure-mistranslation-amino acid analogs-puromycin). Proc Natl Acad Sci U S A 69(2):422–426
Goldberg AL, Dice JF (1974) Intracellular protein degradation in mammalian and bacterial cells. Annu Rev Biochem 43(0):835–869. https://doi.org/10.1146/annurev.bi.43.070174.004155
Goldberg AL (1971) A role of aminoacyl-tRNA in the regulation of protein breakdown in Escherichia coli. Proc Natl Acad Sci U S A 68(2):362–366
Etlinger JD, Goldberg AL (1977) A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc Natl Acad Sci U S A 74(1):54–58
Goldberg AL, Jablecki C, Li JB (1974) Trophic functions of the neuron. 3. Mechanisms of neurotrophic interactions. Effects of use and disuse on amino acid transport and protein turnover in muscle. Ann N Y Acad Sci 228:190–201
Cohen S, Nathan JA, Goldberg AL (2015) Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14(1):58–74. https://doi.org/10.1038/nrd4467
Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17(7):1807–1819. https://doi.org/10.1681/ASN.2006010083
Zhang J, Wang J, Ng S, Lin Q, Shen HM (2014) Development of a novel method for quantification of autophagic protein degradation by AHA labeling. Autophagy 10(5):901–912. https://doi.org/10.4161/auto.28267
Zhang J, Wang J, Lee YM, Lim TK, Lin Q et al (2017) Proteomic profiling of de novo protein synthesis in starvation-induced autophagy using bioorthogonal noncanonical amino acid tagging. Methods Enzymol 588:41–59. https://doi.org/10.1016/bs.mie.2016.09.075
McShane E, Sin C, Zauber H, Wells JN, Donnelly N et al (2016) Kinetic analysis of protein stability reveals age-dependent degradation. Cell 167(3):803–815 e821. https://doi.org/10.1016/j.cell.2016.09.015
Mordier S, Deval C, Bechet D, Tassa A, Ferrara M (2000) Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway. J Biol Chem 275(38):29900–29906. https://doi.org/10.1074/jbc.M003633200
Zhao J, Zhai B, Gygi SP, Goldberg AL (2015) mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy. Proc Natl Acad Sci U S A 112(52):15790–15797. https://doi.org/10.1073/pnas.1521919112
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sha, Z., Zhao, J., Goldberg, A.L. (2018). Measuring the Overall Rate of Protein Breakdown in Cells and the Contributions of the Ubiquitin-Proteasome and Autophagy-Lysosomal Pathways. In: Mayor, T., Kleiger, G. (eds) The Ubiquitin Proteasome System. Methods in Molecular Biology, vol 1844. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8706-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8706-1_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8705-4
Online ISBN: 978-1-4939-8706-1
eBook Packages: Springer Protocols